Patrick Nachman – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailpnachmanumnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

4 Active
8 Finished

4 results

Filter

Active
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy andSafety of Sibeprenlimab Administered Subcutaneously in Subjects withImmunoglobulin A Nephropathy
Nachman, P.
OTSUKA PHARMACEUTICAL DEV. & COMM., INC.
7/24/23 → 3/31/27
Project: Research project
Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics
Nachman, P., Adeyi, O., Berge, J. M., Bu, L., Caramori, L., Drawz, P. E., Flanagan, S. M., Harindhanavudhi, T., Ma, S., Rosenberg, M., Safadi, S. & Wolf, S. M.
NIH NATL INST OF DIABETES/DIG/KIDNEY DIS
9/15/22 → 6/30/27
Project: Research project
Preparing a Clinical Outcomes Assessment set for Nephrotic Syndrome [Prepare-NS]
Nachman, P.
UNIVERSITY OF MICHIGAN, NATIONAL INSTITUTES OF HEALTH (NIH)
5/1/21 → 4/30/26
Project: Research project
OMS721-IGA-001: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)
Nachman, P.
Omeros Corporation
2/1/18 → 12/31/23
Project: Research project